Viewing Study NCT02174835


Ignite Creation Date: 2025-12-24 @ 10:07 PM
Ignite Modification Date: 2026-02-24 @ 5:04 PM
Study NCT ID: NCT02174835
Status: COMPLETED
Last Update Posted: 2014-06-26
First Post: 2014-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers
Sponsor: Avanir Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pharmacokinetics View
None Healthy Volunteers View
None deuterated dextromethorphan View
None deuterated dextromethorphan with quinidine View